All stock lists
Vivos Therapeutics, Inc. (NASDAQ:VVOS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
0.13+0.00 (-3.59%)
Insider Score
––Not scored
VVOS Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
VVOS analyst forecast
Best analysts covering VVOS
- Ascendiant Capital20%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
VVOS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2026-06-04 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2026-04-22 |
| — | HC Wainwright& Co. | Buy | — | — | Reiterated | 2026-04-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-17 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-12-03 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-09-09 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2025-04-15 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2024-11-20 |
| — | Alliance Global Partners | Buy | — | — | Reiterated | 2024-11-19 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2024-08-20 |
| — | Ascendiant Capital | Buy | — | — | Reiterated | 2023-01-17 |
| — | Roth Capital | Buy | — | — | Reiterated | 2021-08-12 |
| — | Roth Capital | Buy | — | — | Reiterated | 2021-05-17 |
| — | Craig-Hallum | Buy | — | — | Reiterated | 2021-01-11 |
| — | Roth Capital | Buy | — | — | Reiterated | 2021-01-05 |
VVOS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-04-15 | -0.49 | -0.58 | $7.1M | $3.8M |
| 2026-05-20 | -0.45 | -0.52 | $4.3M | $5.1M |
| 2026-08-14 | -0.41 | -0.31 | $5.6M | $5.2M |
| 2026-11-18 | -0.30 | 0.00 | $5.5M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.